0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

The Treatment of Schistosomiasis

R. S. DÍAZ-RIVERA, M.D.; F. RAMOS-MORALES, M.D.; Z. R. SOTOMAYOR, M.D.; SYLVIA SANTIAGO, M.D.
AMA Arch Intern Med. 1958;101(6):1151-1158. doi:10.1001/archinte.1958.00260180141016.
Text Size: A A A
Published online

The proper evaluation of the effectiveness of therapy in schistosomiasis is rendered difficult by the protean clinical manifestations of the disease, the invariable tendency toward chronicity, and the lack of accurate information pertaining to the natural course of the disease. From the outset a pessimistic attitude is assumed in view of the failure to discover drugs of definite efficacy. A review of the voluminous medical literature dealing with this subject fails to reveal a single medication that can effectively control the ravages of the disease. Thus, after maturation of the parasite and oviposition, progressive, and at times irreversible, tissue changes occur, emphasizing the early recognition of the disease as the most important governing factor in the determination of the degree of possible therapeutic success in the future. However, it appears as if the direct contact of the adult parasites and their eggs with the host's tissues leads to pathological alterations

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();